These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7800560)

  • 21. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone therapy: role of early and late electrophysiologic studies.
    Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
    J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the results of electrophysiologic testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia.
    Rosenheck S; Sousa J; Calkins H; Schmaltz S; deBuitleir M; Kadish AH; Morady F
    Am Heart J; 1991 Jun; 121(6 Pt 1):1693-8. PubMed ID: 2035383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR; Brodine WN; Gibbs H; Vacek JL
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):864-9. PubMed ID: 1376898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
    Lazzara R
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):473-7. PubMed ID: 7513876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.
    Borggrefe M; Trampisch HJ; Breithardt G
    J Am Coll Cardiol; 1988 Jul; 12(1):140-9. PubMed ID: 3379199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
    Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
    Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
    Seipel L; Kühlkamp V
    Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ; Karagounis LA; Mann DE; Reiffel JA; Hahn E; Hartz V
    Am J Cardiol; 1997 Feb; 79(3):315-22. PubMed ID: 9036751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
    Shannon JA; Hammill SC; Gersh BJ
    Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
    Podrid PJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S44-58. PubMed ID: 1279309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
    Schläpfer J; Rapp F; Kappenberger L; Fromer M
    J Am Coll Cardiol; 2002 Jun; 39(11):1813-9. PubMed ID: 12039497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J; Haines DE; Lerman BB; DiMarco JP
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
    Lavery D; Saksena S
    Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.